@CardiologyTalk

Our goal is to bridge the educational gap confronting medical cardiologist and researchers with video interviews of principal investigators.

 Temecula, CA
cardiologytalk.com
Joined October 2020
  • Tweets335
  • Following2.5K
  • Followers700
330Media
Michael H. Davidson, MD, @mdavidsonmd @NewAmsPharma shares groundbreaking results from the ROSE2 Trial on Obacetrapib! Discover a remarkable LDL cholesterol reduction with Obacetrapib + Ezetimibe, paving the way for aggressive LDL-C goals. 🎯👏 [video] buff.ly/3L7O24V
164
🔬 Marc S. Sabatine, MD, from @BrighamWomens, pioneers MK0616, a Merck PCSK9 inhibitor. LDL cholesterol drops by 60.9% in hypercholesterolemia patients—a potential healthcare game-changer! [video]buff.ly/3sRbM6Z #CardioResearch #LDLCholesterol #Innovation 🌟
108
📢 Obacetrapib & Edizumab combo ROSE2 positive trial results in reduction of LDL cholesterol. Watch Michael Davidson @mdavidsonmd @NewAmsPharma discuss the results buff.ly/3L7O24V
181
Dr. Mason The study highlights the impact of mineral oil, corn oil, EPA, and DHA on phospholipid membrane oxidation rates. @BrighamWomens #Amarincorp #DeepakBhattMD #SamuelSherrattMD #PeterLibbyMD #ACC23 #WCCardio
1
205
Icosapent Ethyl from 🥼 Professor Philippe Steg's discussion on the REDUCE-IT trial. Exciting to explore the remarkable benefits for patients with recent ACS. @APHP #PhilippeStegMD #ACC23 #WCCardio Watch and Share the Video Here: cardiologytalk.com/v/793
1
2
296
@PrestonMasonPhD 🩺- How EPA can modulate platelet activation and thrombosis proteins in vascular endothelial cells during inflammation. @BrighamWomens #DeepakBhattMD #SamuelSherrattMD #PeterLibbyMD #ACC23 #WCCardio Watch and Share the Video Here: cardiologytalk.com/v/791
165
Atrial Fibrillation SOC: An Electrophysiologist Review [2022] @DJ_Lakkireddy @bariatricsurgkc #Electrophysiology #CardioTwitter medicusnetworks.net/3MNb6Fv
Atrial Fibrillation SOC: An Electrophysiologist Review [2022] @DJ_Lakkireddy @bariatricsurgkc #Electrophysiology #CardioTwitter

ALT Atrial Fibrillation SOC: An Electrophysiologist Review [2022] @DJ_Lakkireddy @bariatricsurgkc #Electrophysiology #CardioTwitter

EV ICD Pivotal Study: Will This Eliminate Complications? @drpaulfriedman @MayoClinic @MayoClinicCV #CardioTwitter medicusnetworks.net/3CzlsEy
EV ICD Pivotal Study: Will This Eliminate Complications?

ALT EV ICD Pivotal Study: Will This Eliminate Complications?

EV ICD Pivotal Study: Will This Eliminate Complications? @drpaulfriedman @MayoClinic @MayoClinicCV #CardioTwitter medicusnetworks.net/3S4SRwB
EV ICD Pivotal Study: Will This Eliminate Complications?

ALT EV ICD Pivotal Study: Will This Eliminate Complications?

5
9
Phase 3 REDUCE-IT Trial Prakriti Gaba, MD @PrakritiGaba @DLBHATTMD @BrighamWomens @HarvardMed #REDUCEIT #CardioTwitter hubs.la/Q01bDZc30
Phase 3 REDUCE-IT Trial Prakriti Gaba, MD @PrakritiGaba @DLBHATTMD @BrighamWomens @HarvardMed #REDUCEIT #CardioTwitter

ALT Phase 3 REDUCE-IT Trial Prakriti Gaba, MD @PrakritiGaba @DLBHATTMD @BrighamWomens @HarvardMed #REDUCEIT #CardioTwitter

3
2
18
Podcast - Non-RBC Blood Does Not Reduce Survival Following Surgery Ibrahim Sultan, MD @IbrahimSultanMD @HviUpmc @UPMC @UPMCPhysicianEd #CardioTwitter Link to Audio: hubs.la/Q01bDV0H0
Podcast - Non-RBC Blood Does Not Reduce Survival Following Surgery Ibrahim Sultan, MD @IbrahimSultanMD @HviUpmc @UPMC @UPMCPhysicianEd #CardioTwitter

ALT Podcast - Non-RBC Blood Does Not Reduce Survival Following Surgery Ibrahim Sultan, MD @IbrahimSultanMD @HviUpmc @UPMC @UPMCPhysicianEd #CardioTwitter

3
5
Non-RBC Blood Does Not Reduce Survival Following Surgery Ibrahim Sultan, MD @IbrahimSultanMD @HviUpmc @UPMC @UPMCPhysicianEd #CardioTwitter hubs.la/Q01bDSZ90
Non-RBC Blood Does Not Reduce Survival Following Surgery Ibrahim Sultan, MD @IbrahimSultanMD @HviUpmc @UPMC @UPMCPhysicianEd #CardioTwitter

ALT Non-RBC Blood Does Not Reduce Survival Following Surgery Ibrahim Sultan, MD @IbrahimSultanMD @HviUpmc @UPMC @UPMCPhysicianEd #CardioTwitter

Epi Scar-Homogenization With VS Without Epicardial Ablation Andrea Natale, MD @natale_md @tcainstitute #VT #ICM hubs.la/Q01b4vFV0
Epi Scar-Homogenization With VS Without Epicardial Ablation Andrea Natale, MD @natale_md @tcainstitute #VT #ICM

ALT Epi Scar-Homogenization With VS Without Epicardial Ablation Andrea Natale, MD @natale_md @tcainstitute #VT #ICM

Podcast - Epi Scar-Homogenization With VS Without Epicardial Ablation Andrea Natale, MD @natale_md @tcainstitute #VT #ICM Link to Audio: hubs.la/Q01b4x9g0
Podcast - Epi Scar-Homogenization With VS Without Epicardial Ablation Andrea Natale, MD @natale_md @tcainstitute #VT #ICM

ALT Podcast - Epi Scar-Homogenization With VS Without Epicardial Ablation Andrea Natale, MD @natale_md @tcainstitute #VT #ICM

Phase III ORION-9,10, and 11 Studies Scott Wright, MD @ScottWrightMD @MayoClinic #ORIONStudies hubs.la/Q01b4g9p0
Phase III ORION-9,10, and 11 Studies Scott Wright, MD @ScottWrightMD @MayoClinic #ORIONStudies

ALT Phase III ORION-9,10, and 11 Studies Scott Wright, MD @ScottWrightMD @MayoClinic #ORIONStudies

1
Podcast - Phase III ORION-9,10, and 11 Studies Scott Wright, MD @ScottWrightMD @MayoClinic #ORIONStudies Link to Audio: hubs.la/Q01b48nH0
Phase 2 PACIFIC-AF Study Jonathan P. Piccini, MD @JonPicciniSr @DukeHeartCenter @DukeCardiology #PACIFICAF hubs.la/Q01b4rV00
Phase 2 PACIFIC-AF Study Jonathan P. Piccini, MD @JonPicciniSr @DukeHeartCenter @DukeCardiology #PACIFICAF

ALT Phase 2 PACIFIC-AF Study Jonathan P. Piccini, MD @JonPicciniSr @DukeHeartCenter @DukeCardiology #PACIFICAF

1
1
Podcast - Phase 2 PACIFIC-AF Study Jonathan P. Piccini, MD @JonPicciniSr @DukeHeartCenter @DukeCardiology #PACIFICAF Link to Audio: hubs.la/Q01b4lnd0
Podcast - Phase 2 PACIFIC-AF Study Jonathan P. Piccini, MD @JonPicciniSr @DukeHeartCenter @DukeCardiology #PACIFICAF

ALT Podcast - Phase 2 PACIFIC-AF Study Jonathan P. Piccini, MD @JonPicciniSr @DukeHeartCenter @DukeCardiology #PACIFICAF

1
3
Moving from “Candidacy” To “Benefit Derived” Drs. Lala and Mentz @dranulala @MountSinai @robmentz #JCF #wordsmatter hubs.la/Q01b40_l0
Moving from “Candidacy” To “Benefit Derived” Drs. Lala and Mentz @dranulala @MountSinai @robmentz #JCF #wordsmatter

ALT Moving from “Candidacy” To “Benefit Derived” Drs. Lala and Mentz @dranulala @MountSinai @robmentz #JCF #wordsmatter

5
17
Podcast - Moving from “Candidacy” To “Benefit Derived” Drs. Lala and Mentz @dranulala @MountSinai @robmentz #JCF #wordsmatter Link to Audio: hubs.la/Q01b4lpF0
Podcast - Moving from “Candidacy” To “Benefit Derived” Drs. Lala and Mentz @dranulala @MountSinai @robmentz #JCF #wordsmatter

ALT Podcast - Moving from “Candidacy” To “Benefit Derived” Drs. Lala and Mentz @dranulala @MountSinai @robmentz #JCF #wordsmatter

4
10
Load more